Increased risk of nonalcoholic fatty liver disease in patients with thyroid cancer: a nationwide cohort study
Authors:
Open Access
- 1 July 2025
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 25 (1) , 1-10
Abstract
Background: Given that patients with thyroid cancer experience several metabolic disorders, it is inferred that these patients have an elevated risk of non-alcoholic fatty liver disease (NAFLD). However, large-scale studies on this topic are lacking. This study aimed to elucidate the association between thyroid cancer and NAFLD. Methods: We used data from the Korean National Health Insurance Service Sample Cohort. A total of 1,407 patients with thyroid cancer and 4,221 matched controls were included following the exclusion process and propensity score matching at a ratio of 1:3. We analyzed hazard ratio, risk factors for NAFLD. Results: The study revealed an increased risk of NAFLD (HR 2.28; 95% CI 1.69–3.10; P < 0.001) in patients with thyroid cancer. Thyroid cancer patients exhibited a higher risk of NAFLD when they had no regular exercise (HR 2.41; 95% CI 1.75–3.32). Moreover, body mass index (BMI) and levothyroxine dosage have been identified as potential critical factors for the development of NAFLD in patients with thyroid cancer. Conclusion: The incidence rate of NAFLD was higher in patients with thyroid cancer than in the controls. Healthcare professionals should consider regular physical activity, BMI, and cumulative levothyroxine dosage when managing patients with thyroid cancer to mitigate the incidence of NAFLD.Keywords
Funding Information
- Konkuk University Medical Center
This publication has 29 references indexed in Scilit:
- Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASHTransplantation, 2019
- Systematic Review of Trends in the Incidence Rates of Thyroid CancerThyroid®, 2016
- Obesity is an independent risk factor for non‐alcoholic fatty liver disease: evidence from a meta‐analysis of 21 cohort studiesObesity Reviews, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Thyroid Hormone Regulation of MetabolismPhysiological Reviews, 2014
- Decreased Lipid Intermediate Levels and Lipid Oxidation Rates Despite Normal Lipolysis in Patients with HypothyroidismThyroid®, 2010
- Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinomaEndocrine, 2010
- Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failureTranslational Research, 2008
- Effect of Levothyroxine Replacement on Lipid Profile and Intima-Media Thickness in Subclinical Hypothyroidism: A Double-Blind, Placebo- Controlled StudyThe Journal of Clinical Endocrinology & Metabolism, 2004
- Lipoprotein Profile in Subclinical Hypothyroidism: Response to Levothyroxine Replacement, a Randomized Placebo-Controlled StudyThe Journal of Clinical Endocrinology & Metabolism, 2002